🇺🇸 FDA
Patent

US 12257266

Stem cell-derived exosomes for the treatment of corneal scarring

granted A61KA61K31/7105A61K9/0019

Quick answer

US patent 12257266 (Stem cell-derived exosomes for the treatment of corneal scarring) held by The Regents of the University of California expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/7105, A61K9/0019, A61K9/0048, A61K9/5184